Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Efficacy and Safety of HR19034 Eye Drops for Slowing the Progression of Myopia in Children: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Phase II/III Clinical Trial

NCT07844356 is registered in ClinicalTrials.gov with Chengdu Suncadia Medicine Co., Ltd. as lead sponsor.

NCT NCT07844356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Efficacy and Safety of HR19034 Eye Drops for Slowing the Progression of Myopia in Children: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Phase II/III Clinical Trial
Lead sponsor
Chengdu Suncadia Medicine Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
October 14, 2021
Completion date
July 25, 2025
Enrollment
509 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

slowing the progression of myopia in children